These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26923505)

  • 1. Interactions Between Anandamide and Corticotropin-Releasing Factor Signaling Modulate Human Amygdala Function and Risk for Anxiety Disorders: An Imaging Genetics Strategy for Modeling Molecular Interactions.
    Demers CH; Drabant Conley E; Bogdan R; Hariri AR
    Biol Psychiatry; 2016 Sep; 80(5):356-62. PubMed ID: 26923505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety.
    Gray JM; Vecchiarelli HA; Morena M; Lee TT; Hermanson DJ; Kim AB; McLaughlin RJ; Hassan KI; Kühne C; Wotjak CT; Deussing JM; Patel S; Hill MN
    J Neurosci; 2015 Mar; 35(9):3879-92. PubMed ID: 25740517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity.
    Gunduz-Cinar O; MacPherson KP; Cinar R; Gamble-George J; Sugden K; Williams B; Godlewski G; Ramikie TS; Gorka AX; Alapafuja SO; Nikas SP; Makriyannis A; Poulton R; Patel S; Hariri AR; Caspi A; Moffitt TE; Kunos G; Holmes A
    Mol Psychiatry; 2013 Jul; 18(7):813-23. PubMed ID: 22688188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of Anandamide Hydrolysis in the Basolateral Complex of Amygdala Reduces Fear Memory Expression and Indices of Stress and Anxiety.
    Morena M; Aukema RJ; Leitl KD; Rashid AJ; Vecchiarelli HA; Josselyn SA; Hill MN
    J Neurosci; 2019 Feb; 39(7):1275-1292. PubMed ID: 30573646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive Increases in Amygdalar Corticotropin-Releasing Factor and Fatty Acid Amide Hydrolase Drive an Anxious Phenotype.
    Natividad LA; Buczynski MW; Herman MA; Kirson D; Oleata CS; Irimia C; Polis I; Ciccocioppo R; Roberto M; Parsons LH
    Biol Psychiatry; 2017 Oct; 82(7):500-510. PubMed ID: 28209423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anandamide Signaling Augmentation Rescues Amygdala Synaptic Function and Comorbid Emotional Alterations in a Model of Epilepsy.
    Colangeli R; Morena M; Pittman QJ; Hill MN; Teskey GC
    J Neurosci; 2020 Jul; 40(31):6068-6081. PubMed ID: 32601243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of corticotropin-releasing hormone receptor1 gene variation on psychosocial stress reaction via the dorsal anterior cingulate cortex in healthy adults.
    Li C; Sun X; Dong D; Zhong X; Wang X; Yao S
    Brain Res; 2019 Mar; 1707():1-7. PubMed ID: 30447186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of FAAH genetic variation on fronto-amygdala function during emotional processing.
    Gärtner A; Dörfel D; Diers K; Witt SH; Strobel A; Brocke B
    Eur Arch Psychiatry Clin Neurosci; 2019 Mar; 269(2):209-221. PubMed ID: 30291441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function.
    Hariri AR; Gorka A; Hyde LW; Kimak M; Halder I; Ducci F; Ferrell RE; Goldman D; Manuck SB
    Biol Psychiatry; 2009 Jul; 66(1):9-16. PubMed ID: 19103437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing.
    Weber H; Richter J; Straube B; Lueken U; Domschke K; Schartner C; Klauke B; Baumann C; Pané-Farré C; Jacob CP; Scholz CJ; Zwanzger P; Lang T; Fehm L; Jansen A; Konrad C; Fydrich T; Wittmann A; Pfleiderer B; Ströhle A; Gerlach AL; Alpers GW; Arolt V; Pauli P; Wittchen HU; Kent L; Hamm A; Kircher T; Deckert J; Reif A
    Mol Psychiatry; 2016 Jun; 21(6):813-22. PubMed ID: 26324098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAAH genetic variation enhances fronto-amygdala function in mouse and human.
    Dincheva I; Drysdale AT; Hartley CA; Johnson DC; Jing D; King EC; Ra S; Gray JM; Yang R; DeGruccio AM; Huang C; Cravatt BF; Glatt CE; Hill MN; Casey BJ; Lee FS
    Nat Commun; 2015 Mar; 6():6395. PubMed ID: 25731744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged and site-specific over-expression of corticotropin-releasing factor reveals differential roles for extended amygdala nuclei in emotional regulation.
    Regev L; Neufeld-Cohen A; Tsoory M; Kuperman Y; Getselter D; Gil S; Chen A
    Mol Psychiatry; 2011 Jul; 16(7):714-28. PubMed ID: 20548294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fear extinction learning and anandamide: an fMRI study in healthy humans.
    Spohrs J; Ulrich M; Grön G; Prost M; Plener PL; Fegert JM; Bindila L; Abler B
    Transl Psychiatry; 2021 Mar; 11(1):161. PubMed ID: 33723207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human fear acquisition deficits in relation to genetic variants of the corticotropin-releasing hormone receptor 1 and the serotonin transporter--revisited.
    Heitland I; Groenink L; van Gool JM; Domschke K; Reif A; Baas JM
    Genes Brain Behav; 2016 Feb; 15(2):209-20. PubMed ID: 26643280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma.
    Lazary J; Eszlari N; Juhasz G; Bagdy G
    Eur Neuropsychopharmacol; 2016 Jun; 26(6):1020-8. PubMed ID: 27005594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of anxiety-like behavior and Crhr1 expression in the basolateral amygdala by LMO3.
    Savarese A; Lasek AW
    Psychoneuroendocrinology; 2018 Jun; 92():13-20. PubMed ID: 29609111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism in the corticotropin-releasing factor receptor 1 (CRF1-R) gene plays a role in shaping the high anxious phenotype of Marchigian Sardinian alcohol-preferring (msP) rats.
    Cippitelli A; Ayanwuyi LO; Barbier E; Domi E; Lerma-Cabrera JM; Carvajal F; Scuppa G; Li H; Ubaldi M; Heilig M; Roberto M; Ciccocioppo R
    Psychopharmacology (Berl); 2015 Mar; 232(6):1083-93. PubMed ID: 25260340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic stress-induced alterations in amygdala responsiveness and behavior--modulation by trait anxiety and corticotropin-releasing factor systems.
    Sandi C; Cordero MI; Ugolini A; Varea E; Caberlotto L; Large CH
    Eur J Neurosci; 2008 Nov; 28(9):1836-48. PubMed ID: 18973598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine Facilitates Fear Extinction Through Amygdala Endocannabinoids.
    Gunduz-Cinar O; Flynn S; Brockway E; Kaugars K; Baldi R; Ramikie TS; Cinar R; Kunos G; Patel S; Holmes A
    Neuropsychopharmacology; 2016 May; 41(6):1598-609. PubMed ID: 26514583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.